Antitrust Division may block depositions in Teva securities suit, court says
A Connecticut federal judge has said the Department of Justice can intervene in private litigation against Teva Pharmaceuticals, accepting the Antitrust Division’s arguments that certain depositions and discovery could compromise the integrity of its investigation into price-fixing in the generic pharmaceuticals industry.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10